What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q2 2015?

187 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 170,504,990
Total 13F shares: 98,249,994
Share change: +896,261
Total reported value: $4,115,830,564
Put/Call ratio: 106%
Price per share: $41.88
Number of holders: 187
Value change: +$65,989,817
Number of buys: 90
Number of sells: 97

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	12%	20,481,442	$667,490,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	8.8%	15,025,757	$489,689,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.6%	6,057,423	$197,411,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	3%	5,131,359	$167,231,000	—	31 Mar 2015	13F
OppenheimerFunds, Inc.	13F	Company	2.2%	3,709,507	$120,893,000	—	31 Mar 2015	13F
Capital World Investors	13F	Company	2%	3,451,400	$112,481,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	1.9%	3,276,380	$106,777,000	—	31 Mar 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.7%	2,814,149	$91,713,000	—	31 Mar 2015	13F
WADDELL & REED FINANCIAL INC	13F	Company	1.5%	2,636,471	$85,922,000	—	31 Mar 2015	13F
JENNISON ASSOCIATES LLC	13F	Company	1.5%	2,481,221	$80,863,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.4%	2,424,378	$79,010,000	—	31 Mar 2015	13F
Point72 Asset Management, L.P.	13F	Company	1.3%	2,247,300	$73,240,000	—	31 Mar 2015	13F
FRANKLIN RESOURCES INC	13F	Company	1.2%	2,087,000	$68,016,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	1.1%	1,929,610	$62,887,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.8%	1,359,688	$44,311,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.68%	1,167,064	$38,035,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.59%	1,013,871	$33,039,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.53%	895,810	$29,194,000	—	31 Mar 2015	13F
HealthCor Management, L.P.	13F	Company	0.43%	725,000	$23,628,000	—	31 Mar 2015	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	0.41%	705,301	$22,986,000	—	31 Mar 2015	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.41%	700,856	$22,841,000	—	31 Mar 2015	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.4%	681,131	$22,198,000	—	31 Mar 2015	13F
NORGES BANK	13F	Company	0.38%	642,203	$20,929,000	—	31 Mar 2015	13F
FEDERATED HERMES, INC.	13F	Company	0.37%	633,400	$20,643,000	—	31 Mar 2015	13F
BAMCO INC /NY/	13F	Company	0.36%	607,100	$19,785,000	—	31 Mar 2015	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.35%	600,240	$19,562,000	—	31 Mar 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.31%	528,576	$17,226,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	511,522	$16,671,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	503,886	$16,420,000	—	31 Mar 2015	13F
HARVEY CAPITAL MANAGEMENT INC	13F	Company	0.3%	503,300	$16,402,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	0.28%	471,381	$15,363,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.25%	426,755	$13,908,000	—	31 Mar 2015	13F
Allen Investment Management, LLC	13F	Company	0.24%	414,459	$13,507,000	—	31 Mar 2015	13F
Tourbillon Capital Partners, L.P.	13F	Company	0.23%	400,000	$13,036,000	—	31 Mar 2015	13F
Neuberger Berman Group LLC	13F	Company	0.23%	391,600	$12,762,000	—	31 Mar 2015	13F
LORD, ABBETT & CO. LLC	13F	Company	0.23%	383,759	$12,507,000	—	31 Mar 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.21%	355,803	$11,596,000	—	31 Mar 2015	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.19%	317,235	$10,339,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.17%	290,293	$9,462,000	—	31 Mar 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.17%	286,375	$9,333,000	—	31 Mar 2015	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.16%	271,100	$8,835,000	—	31 Mar 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.15%	260,914	$8,503,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.15%	257,148	$8,381,000	—	31 Mar 2015	13F
PointState Capital LP	13F	Company	0.15%	250,000	$8,148,000	—	31 Mar 2015	13F
PFM Health Sciences, LP	13F	Company	0.15%	249,855	$8,143,000	—	31 Mar 2015	13F
Bellevue Asset Management AG	13F	Company	0.14%	231,000	$7,528,000	—	31 Mar 2015	13F
Asset Management One Co., Ltd.	13F	Company	0.13%	217,705	$7,260,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.13%	219,708	$7,160,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.12%	211,952	$6,908,000	—	31 Mar 2015	13F
GROUP ONE TRADING LLC	13F	Company	0.12%	206,999	$6,746,000	—	31 Mar 2015	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q2 2015

As of 30 Jun 2015, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 187 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,249,994 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, Capital World Investors, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, and FRANKLIN RESOURCES INC. This page lists 187 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

193

Q2 2015 holders

187

Holder diff

-6

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.